Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01776008
Title Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)

Her2-receptor negative breast cancer


Goserelin + MK2206

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST